Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Catalyst Pharmaceuticals Inc CPRX

Healthcare Biotechnology
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for... see more

Recent & Breaking News (NDAQ:CPRX)

Prana Biotechnology Stock Hits New Low

Accesswire April 16, 2014

Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering

GlobeNewswire April 8, 2014

Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock

GlobeNewswire April 3, 2014

Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock

GlobeNewswire April 2, 2014

Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome

GlobeNewswire April 1, 2014

Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM)

GlobeNewswire March 28, 2014

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse(TM)

GlobeNewswire March 25, 2014

Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update

GlobeNewswire March 19, 2014

Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference

GlobeNewswire March 6, 2014

Catalyst Pharmaceutical Partners Observes Rare Disease Day Today

GlobeNewswire February 28, 2014

Catalyst Pharmaceutical Partners to Present at 16th Annual BIO CEO & Investor Conference

Globe Newswire February 6, 2014

Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets

Globe Newswire January 8, 2014

Catalyst Pharmaceutical Partners Reports Dismissal of Stockholder Class Action Lawsuit

Globe Newswire January 7, 2014

Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program

Globe Newswire January 6, 2014

Glancy Binkow & Goldberg LLP Announces a December 24, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. -- CPRX

Globe Newswire December 20, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013

Business Wire December 17, 2013

EQUITY ALERT: Rosen Law Firm Reminds Catalyst Pharmaceutical Partners Investors of Important December 24, 2013 Deadline in Class Action -- CPRX

Globe Newswire December 17, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX

Marketwired December 12, 2013

Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc.

Business Wire December 10, 2013

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Catalyst Pharmaceutical Partners, Inc. of Upcoming Deadline

Business Wire December 9, 2013